Inflammatory breast cancer (IBC) is a rare and aggressive disease that accounts for~ 2–4%
of all breast cancers. However, despite its low incidence rate, IBC is responsible for 7–10 …

MicroRNA (miRNA) is a class of small non-coding RNAs which mediate post-transcriptional
gene silencing (PTGS) by sequence-specific inhibition of target mRNAs translation and/or …

Development of novel approaches for regulating the expression of angiotensin-converting
enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming …

Current next-generation RNA-sequencing (RNA-seq) methods do not provide accurate
quantification of small RNAs within a sample, due to sequence-dependent biases in capture …

Background Maternal breast milk (MBM) is enriched in microRNAs, factors that regulate
protein translation throughout the human body. MBM from mothers of term and preterm …

Emerging evidence has found that microRNAs (miRNA) play an important role in breast
cancer. MiR-548 family has been demonstrated to be involved in the pathogenesis of …

Inflammatory breast cancer (IBC) is a rare yet aggressive breast cancer variant, associated
with a poor prognosis. The major challenge for IBC is misdiagnosis due to the lack of …

Hypoxia is an extensively investigated condition due to its contribution to various
pathophysiological processes including cancer progression and metastasis formation …

Analysis of regulatory networks is a powerful framework for identification and quantification
of intracellular interactions. We introduce miRGTF-net, a novel tool for construction of miRNA …

Identification of disease-related microRNAs (disease miRNAs) is helpful for understanding
and exploring the etiology and pathogenesis of diseases. Most of recent methods predict …